HPLC purity
Target specification: ≥99% area purity by reverse-phase HPLC with UV detection; actual acceptance criteria and result are confirmed for the applicable product and lot.
Pepti · Catalog · Thymosin Alpha-1
Immune modulation · worldwide
Thymosin Alpha-1 wholesale & OEM supply.
Lyophilized Thymosin Alpha-1 (Tα-1) for research organizations, qualified B2B buyers, qualified B2B research buyers, and private-label brand owners. ≥99% HPLC purity target, batch-linked COA, HPLC chromatogram and MS identity record. Studied for immune modulation and antiviral research.
Lot TA1-5HPLC ≥ 99%MS confirmed5 mg
Vial illustrations reflect supplied lyophilized format. Lot codes are sample identifiers; production lots carry their own batch references.
| Compound | Thymosin Alpha-1 (Tα-1) |
|---|---|
| Sequence | Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH |
| Molecular weight | ≈ 3108.3 g/mol |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 5 mg, 10 mg |
| Documentation | Batch-document availability confirmed by product, specification and applicable lot |
| Storage | 2–8 °C protected from light; long-term −20 °C |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | 1 kit (10 vials) | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Tα-1 is N-terminally acetylated and supplied as the free-acid form unless specified otherwise. Confirm if your protocol requires a different terminal modification.
Documentation
Every Thymosin α-1 lot ships with a batch document pack for the production lot.
COA, HPLC chromatogram, MS identity confirmation, water content and storage notes. Buyer track and destination confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the Thymosin α-1 reference profile.
Lot traceability
Lot code printed on vial label and reflected in the document pack. Reorders cite the prior lot for continuity.
FAQ
Common Thymosin α-1 questions from B2B buyers.
What is Thymosin Alpha-1?
Thymosin Alpha-1 (Tα-1) is a 28-amino-acid N-terminally acetylated peptide studied for immune modulation and antiviral pathways. Research organizations and qualified B2B research buyers source Tα-1 for individualized protocols.
What is the MOQ?
Sample lots from 1 kit (10 vials); production lots from 200 vials with tier pricing.
Do you supply qualified B2B research buyers?
Yes — qualified B2B research buyers receive context-specific documentation for compounds outside the FDA's 2026 regulated bulk-substance bulks restriction.
Can Tα-1 be private-labeled?
Yes — neutral or branded vial label, carton, and document pack via the OEM service path.
How is batch-document availability confirmed?
Yes. For the applicable lot, Pepti confirms the available document set during RFQ review. Depending on the product and lot, the set can include COA + HPLC + MS document pack and lot traceability.
Related compounds
Buyers sourcing Thymosin Alpha-1 often also source these.
Current Batch COA
Open the Thymosin Alpha-1 Certificate of Analysis.
Batch-linked COA PDF for each Thymosin Alpha-1 specification below, with the reported chromatographic purity and molecular-weight identity results. Independent local verification is welcome. Confirmed quality issues are eligible for replacement or refund under the quality policy.